27 news items
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
REGN
16 Jun 24
medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases. For more
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
CADL
FGEN
ONCY
12 Jun 24
on innovative solutions, including recent developments coming from Oncolytics
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
CADL
FGEN
ONCY
12 Jun 24
, and aggressive nature. In order to significantly enhance patient health outcomes, several biotech developers are actively working on innovative
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
REGN
11 Jun 24
are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve
FDA Extends Review Deadline For Regeneron/Sanofi's Dupixent For 'Smoker's Lungs' Disease
REGN
SNY
31 May 24
Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation
cck71crbdub twvi9n
CRL
IQV
MAIA
31 May 24
in 2023, analysts believe that the innovation driving the sector remains strong.
MAIA Biotechnology
8l26h
REGN
31 May 24
genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases
jo4nd5nf bxlf6v7o3mw10rqqpljl4j
REGN
31 May 24
the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling us to identify innovative targets
7yxg5yswnn4w73lojglcnzykzj1s5qpor0getgif8mei2c
REGN
31 May 24
medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases. For more
v0vjxh0o2iedmqagifr1kji54ytl33d7lluhtqyvq
REGN
31 May 24
platforms, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases. For more
o1h7ca5w6glhhnyn i3usmcrvvcn5bptpg74t6n0kevraca8g0j13dd2
BHVN
REGN
29 May 24
-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. The company is advancing its innovative portfolio
gd42zxj3c9gfaoke72cuvzyx17il7pax76i
REGN
23 May 24
of those affected by one of the most serious diseases of our time. Backed by our legacy of scientific innovation and a deep understanding
q0ftf92krlwkwvzwsto4pnuvd9lem5x5z7khs5jfn orekj
REGN
20 May 24
-powered insights from the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling us to identify innovative
0ql3vawbanm5q767h072j51tdff9xg7rv
REGN
20 May 24
-powered insights from the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling us to identify innovative targets
y7jp3p urs9a6pk3995r980wo
REGN
17 May 24
the $75,000 top award, the George D. Yancopoulos Innovator Award, named in honor of the pioneering drug researcher
ea2z0n4 ccjoqdjuzbv54a0xp
REGN
17 May 24
the $75,000 top award, the George D. Yancopoulos Innovator Award, named in honor of the pioneering drug researcher
cwfs0 ifyfm9r9ggdudvqc
REGN
17 May 24
. Yancopoulos Innovator Award, named in honor of the pioneering drug researcher and Regeneron co-Founder, Board co-Chair, President and Chief Scientific
slkt4dpmc9kzrn
REGN
13 May 24
the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary
0ar2e9a2p elst8vmepuosey2ud9
REGN
8 May 24
, enabling us to identify innovative targets and complementary approaches to potentially treat or cure diseases. For more information, please
v0uhi
REGN
6 May 24
® and pioneering genetic medicine platforms, enabling us to identify innovative targets and complementary approaches to potentially treat